Beijing Genomics Institute (BGI)

Minimum Order
1
Packaging
N/A
Delivery
15 Days
BGI ((BGI China) was founded in 1999 with the vision of using genomics to benefit mankind and has since become the largest genomic organization in the world. With a focus on research and applications in the healthcare, agriculture, conservation, and environmental fields, BGI has a proven track record of innovative, high profile research, which has generated over 2,137 publications, many in top-tier journals such as Nature and Science.
The company also contributes to scientific communication by publishing the international research journal GigaScience.
BGI’s distinguished achievements have made a significant contribution to the development of genomics throughout the world. BGI’s goal is to make state-of-the-art genomics highly accessible to the global research community and clinical markets by integrating the industry’s broadest array of leading technologies, including BGI's own BGISEQ sequencing platform, economies of scale, and expert bioinformatics resources.

BGI also offers a wide portfolio of transformative genetic testing products across major diseases, enabling medical providers and patients worldwide to realize the promise of genomics-based diagnostics and personalized healthcare. BGI’s services and solutions are available in more than 60 countries and regions around the world.
  • Country:
  • Business Type:
  • Market:
  • Founded Year:
  • Address:
  • Contact:Tommy Ru
*Your name:
*Your Email:
*To:BGI Genomics
*Subject:
*Message:
Enter between 20 to 3,000 characters. English only.     Characters : 0 / 3000
*Enter the secure code shown below Mfrbee security Image      Reload Image

submiting now We do inquire for you , please wait ...

Beijing Genomics Institute (BGI)’s First BGISEQ-500 in Asia Pacific has Settled in Taiwan
Beijing Genomics Institute (BGI)’s First BGISEQ-500 in Asia Pacific has Settled in Taiwan

Since its publicity at the end of 2015, it has accumulated over 112,000 sample tests, while its analysis is based the clinical data from more than 1.7 million NIFTY/NIFTY PLUS cases worldwide; it is the only NGS analysis system in the world that has substantial clinical gene ...

BGI Genomics

Natera and BGI Genomics Announce $50M Partnership to Commercialize Signatera Oncology Test in China and to Develop Reproductive Health Tests in Select Markets on BGI's DNBseq™ Technology Platform
Natera and BGI Genomics Announce $50M Partnership to Commercialize Signatera Oncology Test in China and to Develop Reproductive Health Tests in Select Markets on BGI's DNBseq™ Technology Platform

SAN CARLOS, Calif. and SHENZHEN, China, March 11, 2019 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA genetic testing, and BGI Genomics Co., Ltd., (300676.SZ), the largest cell-free DNA clinical testing laboratory in China and one of the ...

BGI Genomics

BGI Genomics
BGI Genomics

BGI was founded in 1999 as a research organization to support the Human Genome Project. Over the years, BGI’s in-house research has contributed to the development of the field of Genomics in significant ways, as evidenced by a wealth of peer-reviewed publications in ...

BGI Genomics